Drug Shortage Report for DEFEROXAMINE MESYLATE FOR INJECTION
| Report ID | 212030 |
| Drug Identification Number | 02247022 |
| Brand name | DEFEROXAMINE MESYLATE FOR INJECTION |
| Common or Proper name | DEFEROXAMINE MESYLATE FOR INJECTION |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEFEROXAMINE MESYLATE |
| Strength(s) | 2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR |
| Packaging size | 2g vial |
| ATC code | V03AC |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-04 |
| Estimated end date | |
| Actual end date | 2024-04-17 |
| Shortage status | Resolved |
| Updated date | 2024-04-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2024-04-18 | French | Compare |
| v14 | 2024-04-18 | English | Compare |
| v13 | 2024-03-05 | English | Compare |
| v12 | 2024-03-04 | French | Compare |
| v11 | 2024-03-04 | English | Compare |
| v10 | 2024-03-01 | English | Compare |
| v9 | 2024-02-05 | French | Compare |
| v8 | 2024-02-05 | English | Compare |
| v7 | 2024-02-05 | French | Compare |
| v6 | 2024-02-05 | English | Compare |
| v5 | 2024-01-31 | English | Compare |
| v4 | 2024-01-19 | French | Compare |
| v3 | 2024-01-19 | English | Compare |
| v2 | 2023-11-30 | French | Compare |
| v1 | 2023-11-30 | English | Compare |
Showing 1 to 15 of 15